GAMMA LINOLENIC ACID

OTHER NAME(S):

Acide Gammalinolénique, Acide Gamma-Linolénique, Ácido Gama Linolénico, AGL, Gamolenic Acid, GLA, Gammalinolenic Acid, Gamma-Linolenic Acid, (Z,Z,Z)-Octadeca-6,9,12-trienoic acid.<br/><br/>

Overview

Overview Information

Gamma linolenic acid is a fatty substance. It's found in various plant seed oils such as borage oil and evening primrose oil. People use it as medicine.

People use gamma linolenic acid (GLA) for conditions such as arthritis, nerve damage due to diabetes, eczema, high blood pressure, and other conditions, but there is no good scientific evidence to support most of these uses.

How does it work?

Gamma linolenic acid is an omega-6 fatty acid. The body converts gamma linolenic acid to substances that reduce inflammation and cell growth.

Uses

Uses & Effectiveness?

Possibly Effective for

  • Nerve damage due to diabetes (diabetic neuropathy). Taking gamma linolenic acid by mouth for 6-12 months seems to reduce symptoms and prevent nerve damage in people with nerve pain due to type 1 or type 2 diabetes. Gamma linolenic acid seems to work better in people with good blood sugar control.

Possibly Ineffective for

  • Eczema. Most research shows that taking gamma linolenic acid by mouth does not improve itchy or dry skin in people with eczema.
  • Scleroderma, a condition in which skin hardens. Taking gamma linolenic acid by mouth does not seem to reduce symptoms of scleroderma.
  • Ulcerative colitis. Taking gamma linolenic acid plus eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) does not reduce symptoms of ulcerative colitis.

Insufficient Evidence for

  • Back pain. Early research shows that taking alpha-lipoic acid plus gamma linolenic acid and going to physical therapy improves back pain intensity better than only going to physical therapy.
  • Breast cancer. Early research shows that taking gamma linolenic acid improves the response to tamoxifen in people with breast cancer.
  • High blood pressure. Some research shows that taking gamma linolenic acid with eicosapentaenoic acid does not decrease modestly high blood pressure. Other research shows that taking gamma linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid for 6 weeks may decrease diastolic (the bottom number) blood pressure.
  • Attention deficit-hyperactivity disorder (ADHD).
  • Cancer prevention.
  • Chronic fatigue syndrome.
  • Depression.
  • Hay fever.
  • Heart disease.
  • High cholesterol.
  • Oral polyps.
  • Psoriasis.
  • Other conditions.
More evidence is needed to rate the effectiveness of gamma linolenic acid for these uses.

Side Effects

Side Effects & Safety

Gamma linolenic acid is POSSIBLY SAFE for most adults when taken by mouth in amounts of no more than 2.8 grams per day for up to a year. It can cause digestive-tract side effects, such as soft stools, diarrhea, belching, and intestinal gas. It can also make blood take longer to clot.

Special Precautions & Warnings:

Pregnancy and breast-feeding: There is not enough reliable information about the safety of taking gamma linolenic acid if you are pregnant or breast-feeding . Stay on the safe side and avoid use.

Bleeding disorders: Gamma linolenic acid might slow blood clotting. There is some concern that it might increase the risk of bruising and bleeding in people with bleeding disorders.

Surgery: Since gamma linolenic acid might slow blood clotting, there is concern that it might increase the risk of extra bleeding during and after surgery. Stop taking gamma linolenic acid at least 2 weeks before a scheduled surgery.

Interactions

Interactions?

Moderate Interaction

Be cautious with this combination

!
  • Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs) interacts with GAMMA LINOLENIC ACID

    Gamma linolenic acid might slow blood clotting. Taking gamma linolenic acid along with medications that also slow clotting might increase the chances of bruising and bleeding.<br/><br/> Some medications that slow blood clotting include aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, others), ibuprofen (Advil, Motrin, others), naproxen (Anaprox, Naprosyn, others), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, warfarin (Coumadin), and others.

  • Phenothiazines interacts with GAMMA LINOLENIC ACID

    Taking gamma linolenic acid with phenothiazines might increase the risk of having a seizure in some people.<br/><br/> Some phenothiazines include chlorpromazine (Thorazine), fluphenazine (Prolixin), trifluoperazine (Stelazine), thioridazine (Mellaril), and others.

Dosing

Dosing

The following doses have been studied in scientific research:

BY MOUTH:

  • For nerve pain due to diabetes: 360 to 480 mg of gamma linolenic acid per day has been used.

View References

REFERENCES:

  • Callaway, J., Schwab, U., Harvima, I., Halonen, P., Mykkanen, O., Hyvonen, P., and Jarvinen, T. Efficacy of dietary hempseed oil in patients with atopic dermatitis. J Dermatolog.Treat. 2005;16(2):87-94. View abstract.
  • Deferne, J. L. and Leeds, A. R. Resting blood pressure and cardiovascular reactivity to mental arithmetic in mild hypertensive males supplemented with blackcurrant seed oil. J.Hum.Hypertens. 1996;10(8):531-537. View abstract.
  • Goyal, A. and Mansel, R. E. A randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J 2005;11(1):41-47. View abstract.
  • Leng, G. C., Lee, A. J., Fowkes, F. G., Jepson, R. G., Lowe, G. D., Skinner, E. R., and Mowat, B. F. Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease. Clin Nutr 1998;17(6):265-271. View abstract.
  • Leventhal, L. J., Boyce, E. G., and Zurier, R. B. Treatment of rheumatoid arthritis with blackcurrant seed oil. Br.J.Rheumatol. 1994;33(9):847-852. View abstract.
  • Middleton, S. J., Naylor, S., Woolner, J., and Hunter, J. O. A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis. Aliment.Pharmacol.Ther. 2002;16(6):1131-1135. View abstract.
  • Mills, D. E., Prkachin, K. M., Harvey, K. A., and Ward, R. P. Dietary fatty acid supplementation alters stress reactivity and performance in man. J Hum.Hypertens. 1989;3(2):111-116. View abstract.
  • Remans, P. H., Sont, J. K., Wagenaar, L. W., Wouters-Wesseling, W., Zuijderduin, W. M., Jongma, A., Breedveld, F. C., and Van Laar, J. M. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects. Eur J Clin Nutr 2004;58(6):839-845. View abstract.
  • Stevens, L., Zhang, W., Peck, L., Kuczek, T., Grevstad, N., Mahon, A., Zentall, S. S., Arnold, L. E., and Burgess, J. R. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids 2003;38(10):1007-1021. View abstract.
  • Theander, E., Horrobin, D. F., Jacobsson, L. T., and Manthorpe, R. Gammalinolenic acid treatment of fatigue associated with primary Sjogren's syndrome. Scand.J Rheumatol. 2002;31(2):72-79. View abstract.
  • van Gool, C. J., Thijs, C., Henquet, C. J., van Houwelingen, A. C., Dagnelie, P. C., Schrander, J., Menheere, P. P., and van den brandt, P. A. Gamma-linolenic acid supplementation for prophylaxis of atopic dermatitis--a randomized controlled trial in infants at high familial risk. Am J Clin Nutr 2003;77(4):943-951. View abstract.
  • Wagner, W. and Nootbaar-Wagner, U. Prophylactic treatment of migraine with gamma-linolenic and alpha- linolenic acids. Cephalalgia 1997;17(2):127-130. View abstract.
  • Yoshimoto-Furuie, K., Yoshimoto, K., Tanaka, T., Saima, S., Kikuchi, Y., Shay, J., Horrobin, D. F., and Echizen, H. Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients. Nephron 1999;81(2):151-159. View abstract.
  • Anon. EPOGAM Capsules. G.D. Searle (South Africa) (Pty) Ltd. January 1990. Available at: http://home.intekom.com/pharm/searle/epogm.html
  • Arnold LE, Kleykamp D, Votolato NA, et al. Gamma-linolenic acid for attention-deficit hyperactivity disorder: Placebo-controlled comparison to D-amphetamine. Biol Psychiatry 1989;25:222-8. View abstract.
  • Belch JJ, Ansell D, Madhok R, et al. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: A double blind placebo controlled study. Ann Rheum Dis 1988;47:96-104. View abstract.
  • Brzeski M, Madhok R, and Capell HA. Evening primrose oil in patients with rheumatoid arthritis and side- effects of non-steroidal anti-inflammatory drugs. Br J Rheumatol 1991;30(5):370-372. View abstract.
  • Chenoy R, Hussain S, Tayob Y, et al. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing (abstract). BMJ 1994;308:501-3. View abstract.
  • Cheung KL. Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in Asia. Aust N Z J Surg 1999;69:492-4.. View abstract.
  • D'Almeida A, Carter JP, Anatol A, Prost C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 1992;19:117-31. View abstract.
  • Deferne, J. L. and Leeds, A. R. The antihypertensive effect of dietary supplementation with a 6-desaturated essential fatty acid concentrate as compared with sunflower seed oil. J Hum.Hypertens. 1992;6(2):113-119. View abstract.
  • Dokholyan RS, Albert CM, Appel LJ, et al. A trial of omega-3 fatty acids for prevention of hypertension. Am J Cardiol 2004;93:1041-3. View abstract.
  • Fan YY, Chapkin RS. Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr 1998;128:1411-4. View abstract.
  • Fiocchi, A., Sala, M., Signoroni, P., Banderali, G., Agostoni, C., and Riva, E. The efficacy and safety of gamma-linolenic acid in the treatment of infantile atopic dermatitis. J.Int.Med.Res. 1994;22(1):24-32. View abstract.
  • Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999;27:1409-20. View abstract.
  • Guivernau M, Meza N, Barja P, Roman O. Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin production. Prostaglandins Leukot Essent Fatty Acids 1994;51:311-6. View abstract.
  • Hansen TM, Lerche A, Kassis V, et al. Treatment of rheumatoid arthritis with prostaglandin E1 precursors cis-linoleic acid and gamma-linolenic acid. Scand J Rheumatol 1983;12:85-8. View abstract.
  • Horrobin DF. The use of gamma-linolenic acid in diabetic neuropathy. Agents Actions Suppl 1992;37:120-44. View abstract.
  • Ito Y, Suzuki K, Imai H, et al. Effects of polyunsaturated fatty acids on atrophic gastritis in a Japanese population. Cancer Lett 2001;163:171-8. View abstract.
  • Jamal GA and Carmichael H. The effects of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Diabet Med 1990;7(4):319-323. View abstract.
  • Jamal GA, Carmichael H. The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Diabet Med 1990;7:319-23. View abstract.
  • Jamal GA. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy. Diabet Med 1994;11:145-9. View abstract.
  • Johnson MM, Swan DD, Surette ME. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr 1997;127:1435-44. View abstract.
  • Kawamura A, Ooyama K, Kojima K, Kachi H, Abe T, Amano K, et al. Dietary supplementation of gamma-linolenic acid improves skin parameters in subjects with dry skin and mild atopic dermatitis. J Oleo Sci. 2011;60(12):597-607. View abstract.
  • Keen H, Payan J, Allawi J, et al. Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group. Diabetes Care 1993;16:8-15. View abstract.
  • Kenny FS, Pinder SE, Ellis IO, et al. Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. Int J Cancer 2000;85:643-8. View abstract.
  • Kruger MC, Coetzer H, de Winter R, et al. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano) 1998;10:385-94. View abstract.
  • Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med 1993;119:867-73. View abstract.
  • Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med 1993;119:867-73. View abstract.
  • Manthorpe, R., Hagen, Petersen S., and Prause, J. U. Primary Sjogren's syndrome treated with Efamol/Efavit. A double-blind cross-over investigation. Rheumatol.Int. 1984;4(4):165-167. View abstract.
  • McIllmurray, M. B. and Turkie, W. Controlled trial of gamma linolenic acid in Duke's C colorectal cancer. Br.Med.J.(Clin.Res.Ed) 5-16-1987;294(6582):1260. View abstract.
  • Menendez JA, Colomer R, Lupu R. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) is a selective estrogen-response modulator in human breast cancer cells: gamma-Linolenic acid antagonizes estrogen receptor-dependent transcriptional activity, transcriptionally represses estrogen receptor expression and synergistically enhances tamoxifen and ICI 182,780 (Faslodex) efficacy in human breast cancer cells. Int J Cancer 2004;10;109:949-54. View abstract.
  • Menendez JA, del Mar Barbacid M, Montero S, et al. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer 2001;37:402-13. View abstract.
  • Miles, E. A., Banerjee, T., Dooper, M. M., M'Rabet, L., Graus, Y. M., and Calder, P. C. The influence of different combinations of gamma-linolenic acid, stearidonic acid and EPA on immune function in healthy young male subjects. Br.J.Nutr. 2004;91(6):893-903. View abstract.
  • Mills, D. E. and Ward, R. Attenuation of psychosocial stress-induced hypertension by gamma-linolenic acid (GLA) administration in rats. Proc.Soc.Exp.Biol.Med. 1984;176(1):32-37. View abstract.
  • Pacht, E. R., DeMichele, S. J., Nelson, J. L., Hart, J., Wennberg, A. K., and Gadek, J. E. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med. 2003;31(2):491-500. View abstract.
  • Pullman-Mooar S, Laposata M, Lem D. Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic acid. Arthritis Rheum 1990;33:1526-33. View abstract.
  • Puolakka J, Makarainen L, Viinikka L, and Ylikorkala O. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. J Reprod Med 1985;30(3):149-153. View abstract.
  • Ranieri M., Sciuscio M., Cortese A. M., Santamato A., Di Teo L., Ianieri G., Bellomo R. G., Stasi M., Megna M. The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life. Int J Immunopathol Pharmacol 2009;22(3 Suppl):45-50. View abstract.
  • Rose DP, Connolly JM, Liu XH. Effects of linoleic acid and gamma-linolenic acid on the growth and metastasis of a human breast cancer cell line in nude mice and on its growth and invasive capacity in vitro. Nutr Cancer 1995;24:33-45. . View abstract.
  • Stainforth JM, Layton AM, Goodfield MJ. Clinical aspects of the use of gamma linolenic acid in systemic sclerosis. Acta Derm Venereol 1996;76:144-6. View abstract.
  • Takwale A, Tan E, Agarwal S, et al. Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial. BMJ 2003;327:1385. View abstract.
  • van der Merwe CF, Booyens J, Joubert HF, van der Merwe CA. The effect of gamma-linolenic acid, an in vitro cytostatic substance contained in evening primrose oil, on primary liver cancer. A double- blind placebo controlled trial. Prostaglandins Leukot Essent Fatty Acids 1990;40:199-202. View abstract.
  • van der Merwe, C. F., Booyens, J., and Katzeff, I. E. Oral gamma-linolenic acid in 21 patients with untreatable malignancy. An ongoing pilot open clinical trial. Br.J.Clin.Pract. 1987;41(9):907-915. View abstract.
  • van Gool CJ, Zeegers MP, Thijs C. Oral essential fatty acid supplementation in atopic dermatitis-a meta-analysis of placebo-controlled trials. Br J Dermatol 2004;150:728-40. View abstract.
  • Wu D, Meydani M, Leka LS, et al. Effect of dietary supplementation with black currant seed oil on the immune response of healthy elderly subjects. Am J Clin Nutr 1999;70:536-43. View abstract.
  • Zurier RB, Furse RK, Rosetti RG. Gamma-linolenic acid (GLA) prevents amplification of interleukin-1-beta (IL-1-beta). Altern Ther 2001;7:112.
  • Zurier RB, Rossetti RG, Jacobson EW, et al. Gamma-linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis Rheum 1996;39:1808-17. View abstract.

More Resources for GAMMA LINOLENIC ACID

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version. © Therapeutic Research Faculty 2009.